- Home
- WLK vs ASND Comparison
WLK vs ASND Comparison
Compare WLK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLK | ASND |
|---|---|---|
| Founded | 1986 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 12.2B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | WLK | ASND |
|---|---|---|
| Price | $67.99 | $205.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 15 |
| Target Price | $88.00 | ★ $256.27 |
| AVG Volume (30 Days) | ★ 1.6M | 640.2K |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,480,000,000.00 | $758,592,045.00 |
| Revenue This Year | N/A | $99.74 |
| Revenue Next Year | $3.18 | $79.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 97.46 |
| 52 Week Low | $56.33 | $118.03 |
| 52 Week High | $128.85 | $223.19 |
Technical Indicators
Market Signals| Indicator | WLK | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 49.03 |
| Support Level | $56.33 | $198.30 |
| Resistance Level | $70.31 | $218.50 |
| Average True Range (ATR) | 2.88 | 9.16 |
| MACD | 1.42 | -0.64 |
| Stochastic Oscillator | 83.23 | 28.05 |
Price Performance
Historical ComparisonAbout WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.